Point72 Hong Kong’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,600
Closed -$411K 294
2022
Q3
$411K Buy
10,600
+9,100
+607% +$365K 0.01% 809
2022
Q2
$56K Sell
1,500
-16,900
-92% -$688K ﹤0.01% 1347
2022
Q1
$815K Sell
18,400
-45,300
-71% -$1.96M 0.03% 575
2021
Q4
$2.71M Buy
63,700
+23,500
+58% +$988K 0.09% 247
2021
Q3
$1.74M Buy
+40,200
New +$1.78M 0.06% 522
2021
Q2
Sell
-22,500
Closed -$870K 1939
2021
Q1
$870K Sell
22,500
-21,400
-49% -$810K 0.03% 691
2020
Q4
$1.58M Buy
+43,900
New +$1.58M 0.07% 340

Other funds holding BSX

Point72 Hong Kong's BSX Position: Q3 2025 in Review

Point72 Hong Kong increased its Boston Scientific (BSX) stake by 625% in Q3 2025, buying an estimated $24.3M and bringing the position to 271,689 shares worth $26.5M. The position accounts for 1.22% of the portfolio, ranked #14.

Point72 Hong Kong first reported a position in BSX in Q1 2015 and has held it in 20 quarters since. 1,709 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Point72 Hong Kong held 271,689 shares of Boston Scientific worth $26.5M as of Q3 2025.
  • Point72 Hong Kong bought 234,224 Boston Scientific shares in Q3 2025, an estimated $24.3M.
  • Boston Scientific made up 1.22% of Point72 Hong Kong's portfolio in Q3 2025, its #14 holding.
  • Point72 Hong Kong first reported a position in Boston Scientific in Q1 2015 and has held it in 20 quarters since.
  • 1,709 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.